DAL
79
-4
MMM
42
5
VRTX
55
2
NVDA
54
2
VFC
50
-2
AAL
51
-3
TAP
63
2
DRI
57
-3
MOS
43
-5
ISRG
74
3
GM
65
-7
PHM
65
-5
BF.B
33
-4
VRSN
58
2
SHW
68
-5
PNW
70
3
CVX
46
8
BRK.B
45
2
UA
57
-8
URBN
50
-2
DAL
79
-4
MMM
42
5
VRTX
55
2
NVDA
54
2
VFC
50
-2
AAL
51
-3
TAP
63
2
DRI
57
-3
MOS
43
-5
ISRG
74
3
GM
65
-7
PHM
65
-5
BF.B
33
-4
VRSN
58
2
SHW
68
-5
PNW
70
3
CVX
46
8
BRK.B
45
2
UA
57
-8
URBN
50
-2
Financhill
Back

SPDR® S&P China ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
27

GXC
SPDR® S&P China ETF

Last Price:
77.06
Seasonality Move:
1.88%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
27
SPDR® S&P China ETF (GXC) is a Sell

Is SPDR® S&P China ETF a Buy, Sell or Hold?

  • The current SPDR® S&P China ETF [GXC] share price is $76.97. The Score for GXC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • GXC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GXC Stock Price Chart

What is SPDR® S&P China ETF's stock price today?

  • The SPDR® S&P China ETF share price today is $76.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GXC is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

GXC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.05 Sell
Relative Strength Index (14 RSI): 45.92 Sell
Chaikin Money Flow: 4422 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.76 - 81.32) Sell
Bollinger Bands (100): (66.09 - 81.11) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GXC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.71 Buy
20-day SMA: 78.68 Sell
50-day SMA: 80.05 Sell
200-day SMA: 71.21 Buy
8-day EMA: 76.68 Buy
20-day EMA: 78.01 Sell
50-day EMA: 77.7 Sell
200-day EMA: 73.19 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

SPDR® S&P China ETF Earnings Growth & GXC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

SPDR® S&P China ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):